PURPOSE: To evaluate patient parameters that may predict for relative differences in cumulative four-dimensional (4D) lung dose among several motion management strategies. METHODS AND MATERIALS: Deformable image registration and dose accumulation were used to generate 4D treatment plans for 18 patients with 4D computed tomography scans. Three plans were generated to simulate breath hold at normal inspiration, target tracking with the beam aperture, and mid-ventilation aperture (control of the target at the mean daily position and application of an iteratively computed margin to compensate for respiration). The relative reduction in mean lung dose (MLD) between breath hold and mid-ventilation aperture (DeltaMLD(BH)) and between target tracking and mid-ventilation aperture (DeltaMLD(TT)) was calculated. Associations between these two variables and parameters of the lesion (excursion, size, location, and deformation) and dose distribution (local dose gradient near the target) were also calculated. RESULTS: The largest absolute and percentage differences in MLD were 1.0 Gy and 21.5% between breath hold and mid-ventilation aperture. DeltaMLD(BH) was significantly associated (p < 0.05) with tumor excursion. The DeltaMLD(TT) was significantly associated with excursion, deformation, and local dose gradient. A linear model was constructed to represent DeltaMLD vs. excursion. For each 5 mm of excursion, target tracking reduced the MLD by 4% compared with the results of a mid-ventilation aperture plan. For breath hold, the reduction was 5% per 5 mm of excursion. CONCLUSIONS: The relative difference in MLD among different motion management strategies varied with patient and tumor characteristics for a given dosimetric target coverage. Tumor excursion is useful to aid in stratifying patients according to appropriate motion management strategies.
PURPOSE: To evaluate patient parameters that may predict for relative differences in cumulative four-dimensional (4D) lung dose among several motion management strategies. METHODS AND MATERIALS: Deformable image registration and dose accumulation were used to generate 4D treatment plans for 18 patients with 4D computed tomography scans. Three plans were generated to simulate breath hold at normal inspiration, target tracking with the beam aperture, and mid-ventilation aperture (control of the target at the mean daily position and application of an iteratively computed margin to compensate for respiration). The relative reduction in mean lung dose (MLD) between breath hold and mid-ventilation aperture (DeltaMLD(BH)) and between target tracking and mid-ventilation aperture (DeltaMLD(TT)) was calculated. Associations between these two variables and parameters of the lesion (excursion, size, location, and deformation) and dose distribution (local dose gradient near the target) were also calculated. RESULTS: The largest absolute and percentage differences in MLD were 1.0 Gy and 21.5% between breath hold and mid-ventilation aperture. DeltaMLD(BH) was significantly associated (p < 0.05) with tumor excursion. The DeltaMLD(TT) was significantly associated with excursion, deformation, and local dose gradient. A linear model was constructed to represent DeltaMLD vs. excursion. For each 5 mm of excursion, target tracking reduced the MLD by 4% compared with the results of a mid-ventilation aperture plan. For breath hold, the reduction was 5% per 5 mm of excursion. CONCLUSIONS: The relative difference in MLD among different motion management strategies varied with patient and tumor characteristics for a given dosimetric target coverage. Tumor excursion is useful to aid in stratifying patients according to appropriate motion management strategies.
Authors: J W Wong; M B Sharpe; D A Jaffray; V R Kini; J M Robertson; J S Stromberg; A A Martinez Journal: Int J Radiat Oncol Biol Phys Date: 1999-07-01 Impact factor: 7.038
Authors: Marcel van Herk; Marnix Witte; Joris van der Geer; Christoph Schneider; Joos V Lebesque Journal: Int J Radiat Oncol Biol Phys Date: 2003-12-01 Impact factor: 7.038
Authors: Tiezhi Zhang; Robert Jeraj; Harry Keller; Weiguo Lu; Gustavo H Olivera; Todd R McNutt; Thomas R Mackie; Bhudatt Paliwal Journal: Med Phys Date: 2004-06 Impact factor: 4.071
Authors: J Hanley; M M Debois; D Mah; G S Mageras; A Raben; K Rosenzweig; B Mychalczak; L H Schwartz; P J Gloeggler; W Lutz; C C Ling; S A Leibel; Z Fuks; G J Kutcher Journal: Int J Radiat Oncol Biol Phys Date: 1999-10-01 Impact factor: 7.038
Authors: George Starkschall; Kenneth M Forster; Kei Kitamura; Alex Cardenas; Susan L Tucker; Craig W Stevens Journal: Int J Radiat Oncol Biol Phys Date: 2004-11-15 Impact factor: 7.038
Authors: Jochem W H Wolthaus; Jan-Jakob Sonke; Marcel van Herk; José S A Belderbos; Maddalena M G Rossi; Joos V Lebesque; Eugène M F Damen Journal: Int J Radiat Oncol Biol Phys Date: 2008-03-15 Impact factor: 7.038
Authors: Carolyn J Niu; Warren D Foltz; Michael Velec; Joanne L Moseley; Adil Al-Mayah; Kristy K Brock Journal: Med Phys Date: 2012-02 Impact factor: 4.071
Authors: Michael Velec; Joanne L Moseley; Cynthia L Eccles; Tim Craig; Michael B Sharpe; Laura A Dawson; Kristy K Brock Journal: Int J Radiat Oncol Biol Phys Date: 2010-08-21 Impact factor: 7.038
Authors: Sean Pollock; Ricky O'Brien; Kuldeep Makhija; Fiona Hegi-Johnson; Jane Ludbrook; Angela Rezo; Regina Tse; Thomas Eade; Roland Yeghiaian-Alvandi; Val Gebski; Paul J Keall Journal: BMC Cancer Date: 2015-07-18 Impact factor: 4.430
Authors: Bin Wang; Da Quan Wang; Mao Sheng Lin; Shi Pei Lu; Jun Zhang; Li Chen; Qi Wen Li; Zhang Kai Cheng; Fang Jie Liu; Jin Yu Guo; Hui Liu; Bo Qiu Journal: BMC Cancer Date: 2020-11-16 Impact factor: 4.430